Sequential activation of caspases and synergistic β-cell cytotoxicity by palmitate and anti-Fas antibodies

Life Sciences

Volumn 79, Issue 13, 2006, Pages 1312-1316

  Hirota, Naotoshi ^a   Otabe, Shuichi ^a   Nakayama, Hitomi ^a   Yuan, Xiaohong ^a   Yamada, Kentaro ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

cell; Apoptosis; Caspase 6; Fas; Lipotoxicity

Indexed keywords

CASPASE 3; CASPASE 6; CASPASE INHIBITOR; FAS ANTIBODY; GLUCOSE; OXFENICINE; PALMITIC ACID;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL CLONE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOCHONDRION; MOUSE; NONHUMAN;

ANIMALS; ANTIBODIES; ANTIGENS, CD95; CARNITINE O-PALMITOYLTRANSFERASE; CASPASE 3; CASPASE 6; CASPASES; CELL DEATH; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME ACTIVATION; GLYCINE; HUMANS; INSULIN-SECRETING CELLS; MICE; PALMITATES; RECEPTOR CROSS-TALK;

EID: 33746911197     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.03.048     Document Type: Article

References (20)

1. Allsopp T.E., McLuckie J., Kerr L.E., Macleod M., Sharkey J., and Kelly J.S. Caspase 6 activity initiates caspase 3 activation in cerebellar granule cell apoptosis. Cell Death and Differentiation 7 10 (2000) 984-993
2. Augstein P., Wachlin G., Berg S., Bahr J., Salzsieder C., Hehmke B., Heinke P., and Salzsieder E. Surface and intracellular Fas expression associated with cytokine-induced apoptosis in rodent islet and insulinoma cells. Journal of Molecular Endocrinology 30 2 (2003) 163-171
3. Chervonsky A.V., Wang Y., Wong F.S., Visintin I., Flavell R.A., Janeway Jr. C.A., and Matis L.A. The role of Fas in autoimmune diabetes. Cell 89 1 (1997) 17-24
4. Cnop M., Hannaert J.C., Hoorens A., Eizirik D.L., and Pipeleers D.G. Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 50 8 (2001) 1771-1777
5. Itoh N., Imagawa A., Hanafusa T., Waguri M., Yamamoto K., Iwahashi H., Moriwaki M., Nakajima H., Miyagawa J., Namba M., Makino S., Nagata S., Kono N., and Matsuzawa Y. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. The Journal of Experimental Medicine 186 4 (1997) 613-618
6. Jacqueminet S., Briaud I., Rouault C., Reach G., and Poitout V. Inhibition of insulin gene expression by long-term exposure of pancreatic beta cells to palmitate is dependent on the presence of a stimulatory glucose concentration. Metabolism 49 4 (2000) 532-536
7. Kurrer M.O., Pakala S.V., Hanson H.L., and Katz J.D. Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proceedings of the National Academy of Sciences of the United States of America 94 1 (1997) 213-218
8. Listenberger L.L., Ory D.S., and Schaffer J.E. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. The Journal of Biological Chemistry 276 18 (2001) 14890-14895
9. Loweth A.C., Williams G.T., James R.F., Scarpello J.H., and Morgan N.G. Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1beta and Fas ligation. Diabetes 47 5 (1998) 727-732
10. Maedler K., Spinas G.A., Lehmann R., Sergeev P., Weber M., Fontana A., Kaiser N., and Donath M.Y. Glucose induces β-cell apoptosis via upregulation of the Fas receptor in human islets. Diabetes 50 8 (2001) 1683-1690
11. Maedler K., Oberholzer J., Bucher P., Spinas G.A., and Donath M.Y. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes 52 3 (2003) 726-733
12. McGarry J.D., and Brown N.F. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. European Journal of Biochemistry 244 1 (1997) 1-14
13. Poitout V., and Robertson R.P. Minireview: Secondary beta-cell failure in type 2 diabetes - a convergence of glucotoxicity and lipotoxicity. Endocrinology 143 2 (2002) 339-342
14. Rakatzi I., Mueller H., Ritzeler O., Tennagels N., and Eckel J. Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1. Diabetologia 47 2 (2004) 249-258
15. Roche E., Farfari S., Witters L.A., Assimacopoulos-Jeannet F., Thumelin S., Brun T., Corkey B.E., Saha A.K., and Prentki M. Long-term exposure of beta-INS cells to high glucose concentrations increases anaplerosis, lipogenesis, and lipogenic gene expression. Diabetes 47 7 (1998) 1086-1094
16. Takahashi A., Hirata H., Yonehara S., Imai Y., Lee K.K., Moyer R.W., Turner P.C., Mesner P.W., Okazaki T., Sawai H., Kishi S., Yamamoto K., Okuma M., and Sasada M. Affinity labeling displays the stepwise activation of ICE-related proteases by Fas, staurosporine, and CrmA-sensitive caspase-8. Oncogene 14 23 (1997) 2741-2752
17. Unger R.H. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44 8 (1995) 863-870
18. Yamada K., Takane-Gyotoku N., Yuan X., Ichikawa F., Inada C., and Nonaka K. Mouse islet cell lysis mediated by interleukin-1-induced Fas. Diabetologia 39 11 (1996) 1306-1312
19. Yamada K., Ichikawa F., Ishiyama-Shigemoto S., Yuan X., and Nonaka K. Essential role of caspase-3 in apoptosis of mouse beta-cells transfected with human Fas. Diabetes 48 2 (1999) 478-483
20. Zhou Y.P., and Grill V.E. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. The Journal of Clinical Investigation 93 2 (1994) 870-876